drugset / Trial / NCT00435370

Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia

NCT00435370 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will determine the effectiveness of tropisetron plus risperidone in improving cognitive symptoms in Chinese people with schizophrenia.

Timeline

Start
2006-11
Primary completion
2011-02
Completion
2011-08

Outcome

Met primary endpoint

registry analysis (superiority or other test); Tropisetron vs Placebo; p <0.05; ANCOVA NCT00435370 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tropisetron Small molecule 10 mg Oral
Background Risperidone Other / unclassified 6 mg —

Indications